ID: ALA4208331

Max Phase: Preclinical

Molecular Formula: C27H32O6

Molecular Weight: 452.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C1C(=O)O[C@@H]2C3=C(C)[C@@H](OC(=O)c4ccc(CCC)cc4)CC3[C@](C)(OC(C)=O)CC[C@@H]12

Standard InChI:  InChI=1S/C27H32O6/c1-6-7-18-8-10-19(11-9-18)26(30)31-22-14-21-23(16(22)3)24-20(15(2)25(29)32-24)12-13-27(21,5)33-17(4)28/h8-11,20-22,24H,2,6-7,12-14H2,1,3-5H3/t20-,21?,22-,24-,27+/m0/s1

Standard InChI Key:  AINHPYLGGCBFBD-DVAKBSPTSA-N

Associated Targets(Human)

QGY-7703 248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SMMC-7721 5516 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 452.55Molecular Weight (Monoisotopic): 452.2199AlogP: 4.71#Rotatable Bonds: 5
Polar Surface Area: 78.90Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: 2.15

References

1. Chen H, Yang X, Yu Z, Cheng Z, Yuan H, Zhao Z, Wu G, Xie N, Yuan X, Sun Q, Zhang W..  (2018)  Synthesis and biological evaluation of α-santonin derivatives as anti-hepatoma agents.,  149  [PMID:29499490] [10.1016/j.ejmech.2018.02.073]

Source